¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • bound coagulase
    ±Õü°áÇÕÇ÷ÀåÀÀ°íÈ¿¼Ò
  • brancher enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • breathing ferment
    È£Èí¹ßÈ¿¼Ò
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • coagulase
    Ç÷ÀåÀÀ°íÈ¿¼Ò
  • coenzyme
    º¸Á¶È¿¼Ò
  • cohort effect
    ÄÚȣƮȿ°ú
  • colipase
    Áö¹æºÐÇØº¸Á¶È¿¼Ò, ÄÚ¸®ÆÄ¾ÆÁ¦
  • collagenase
    ¾Æ±³ÁúºÐÇØÈ¿¼Ò, Äݶó°ÕºÐÇØÈ¿¼Ò
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • combined effect
    º´¿ëÈ¿°ú
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • carbamoyltransferase
    Ä«¸£¹Ù¸ðÀÏÀüÀÌÈ¿¼Ò
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • kininase
    Ű´ÑÈ¿¼Ò
  • keratinase
    °¢ÁúºÐÇØÈ¿¼Ò
  • lipase
    ÁöÁúºÐÇØÈ¿¼Ò
  • lactase
    Á¥´çºÐÇØÈ¿¼Ò
  • metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • nucleotidase
    ´ºÅ¬·¹¿ÀƼµåºÐÇØÈ¿¼Ò
  • oxidase
    »êÈ­È¿¼Ò
  • plasmin
    Çö󽺹Î, ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò
  • peroxidase
    °ú»êÈ­È¿¼Ò
  • phosphatase
    ÀλêºÐÇØÈ¿¼Ò
  • phosphorylase
    ÀλêÈ­È¿¼Ò
  • peptidase
    ÆéƼµåºÐÇØÈ¿¼Ò
  • proteinase
    ´Ü¹éºÐÇØÈ¿¼Ò
  • protease
    ´Ü¹éºÐÇØÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • bound coagulase
    ±Õü°áÇÕÇ÷ÀåÀÀ°íÈ¿¼Ò
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • breathing ferment
    È£Èí¹ßÈ¿¼Ò
  • bridle effect
    °í»ßÈ¿°ú, Á¦¾îÈ¿°ú
  • carboxypeptidase
    Ä«¸£º¹½ÃÆéƼµåºÐÇØÈ¿¼Ò
  • chitinase
    ŰƾºÐÇØÈ¿¼Ò
  • coagulase
    Ç÷ÀåÀÀ°íÈ¿¼Ò
  • coenzyme
    º¸Á¶È¿¼Ò
  • colipase
    Áö¹æºÐÇØº¸Á¶È¿¼Ò, ÄÚ¸®ÆÄ¾ÆÁ¦
  • collagenase
    ¾Æ±³ÁúºÐÇØÈ¿¼Ò
  • convertase
    Àüȯȿ¼Ò
  • cytozyme
    ¼¼Æ÷È¿¼Ò
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carry-over effect
    ÀÜÈ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • EPNDB =effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½·¹º§, ½ÇÁ¦°¨°¢¼ÒÀ½
  • EPNDB=ÊÝeffective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½·¹º§.
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • Fahraeus-Lindqvist effect
    ÆÄ·¹¿ì½º-¸°Äûºñ½ºÆ® È¿°ú(üùÍý)
  • Fenn effect
    Ææ È¿°ú(üùÍý)
  • GDH= glycerophosphate dehydrogenase
    ±Û¸®¼¼·ÎÀλêÅ»¼ö¼ÒÈ¿¼Ò.
  • GOD= glucose oxidase
    Æ÷µµ´ç»êÈ­ È¿¼Ò.
  • GOT= glutamic oxalacetic transaminase
    ±Û·çŸ¹Î¿Á»ìÃÊ»êÀüÀÌÈ¿¼Ò.
  • Gelatinase
    Á©¶óƾºÐÇØÈ¿¼Ò(ÝÂú°ý£áÈ)
  • Gibbs effect
    ±é½º È¿°ú
  • Glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ¿À½º-6-Àλê(×òß«)Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • Glutaminase
    ±Û·çŽ»êºÐÇØÈ¿¼Ò(ÝÂú°ý£áÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • enzymes
    È¿¼Ò(ý£áÈ)
  • enzymes
    È¿¼Ò(ý£áÈ)
  • enzyme
    È¿¼Ò(ý£áÈ).
  • enzyme-antibody conjugate
    È¿¼Ò-Ç×ü ¹èÇÕü
  • ase =enzyme
    È¿¼Ò.
  • enzymatic defect
    È¿¼Ò°á¼Õ(Áõ)(ý£áÈÌÀáßñø).
  • enzyme deficiency
    È¿¼Ò°áÇÌ(Áõ)
  • enzymopenic
    È¿¼Ò°áÇÌÀÇ.
  • enzymoprivic
    È¿¼Ò°áÇÌÁõÀÇ.
  • enzymic antagonist
    È¿¼Ò±æÇ×Á¦.
  • enzyme glaucoma
    È¿¼Ò³ì³»Àå
  • enzymuria
    È¿¼Ò´¢Áõ(¡­èññø).
  • enzyme-multiplied/mediated immunoassay
    È¿¼Ò´ÙÁß/¸Å°³ ¸é¿ªÃøÁ¤(¹ý)
  • zymoprotein
    È¿¼Ò´Ü¹éÁú(ý£áÈÓ±ÛÜòõ).
  • enzyme immunoassay
    È¿¼Ò¸é¿ªÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • antioxidase
    Ç×»êÈ­È¿¼Ò(ù÷ß«ûùý£áÈ).
  • antiprotease
    Ç״ܹéÈ¿¼Ò(ù÷Ó±ÛÜý£áÈ)
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú.
  • antitussive effect
    ÁøÇØÈ¿°ú(òåú¦üùÍý).
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • apoenzyme
    ¾ÆÆ÷È¿¼Ò.
  • apoenzyme
    ¾ÆÆ÷È¿¼Ò
  • apoenzyme portion
    ¾ÆÆ÷È¿¼Ò ºÎºÐ
  • arginine decarboxylase reagent
    ¾Æ¸£±â´ÑŻī¸£º¹½ÇÈ¿¼Ò<--µ¥Ä«¸£º¹½Ç¶óÁ¦
  • arginosuccinic lyase
    ¾Æ¸£±â´ÑÈ£¹Ú»ê¸®¾ÆÁ¦<--Àý´ÜÈ¿¼Ò>
  • artificial age hardening
    Àΰø½ÃÈ¿°æÈ­(ìÑÍïãÁüùÌãûù).
  • ascosporogenous yeast
    À¯Æ÷ÀÚÈ¿¸ð(êóøàí­ý£Ù½).
  • ascosporogenous yeast
    À¯Æ÷ÀÚÈ¿¸ð(êóøàí­ý£Ù½).
  • ase =enzyme
    È¿¼Ò.
  • assay
    Á¤·®, ¿ª°¡°ËÁ¤, È¿·Â°ËÁ¤.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • enzyme analogue
    È¿¼ÒÀ¯»çü(ý£áÈëºÞÄô÷)
  • proenzyme
    È¿¼ÒÀü±¸Ã¼(ý£áÈîñÏÌô÷)
  • enzyme electrode
    È¿¼ÒÀü±Ø(ý£áÈï³Ð¿)
  • enzymoelectrophoresis
    È¿¼ÒÀü±â¿µµ¿(ý£áÈï³Ñ¨ç¶ÔÑ)
  • enzyme species
    È¿¼ÒÁ¾(ý£áÈðú)
  • enzyme therapy
    È¿¼ÒÄ¡·á (ý£áÈö½Öû)
  • enzyme-specific electrode
    È¿¼ÒƯÀÌ Àü±Ø (ý£áÈ÷åì¶ï³Ð¿)
  • enzyme specificity
    È¿¼ÒƯÀ̼º(ý£áÈ÷åì¶àõ)
  • enzyme labeling
    È¿¼ÒÇ¥Áö(ý£áÈøöò½)
  • enzymology
    È¿¼ÒÇÐ(ý£áÈùÊ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • efficiency
    È¿À²(üù×Ë)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • coenzyme II
    "º¸È¿¼Ò(ÜÍý£áÈ) II,(ÔÒ) NADP"
  • coenzyme A
    º¸È¿¼Ò(ÜÍý£áÈ) A
  • coenzyme B12
    "º¸È¿¼Ò(ÜÍý£áÈ) B12, (ÔÒ) cobamide"
  • coenzyme-coupled reactions
    º¸È¿¼Ò(ÜÍý£áÈ)¦Áö¿ò ¹ÝÀÀ
  • coenzyme F
    "º¸È¿¼Ò(ÜÍý£áÈ) F, (ÔÒ) folate coenzyme"
  • coenzyme M
    "º¸È¿¼Ò(ÜÍý£áÈ) M, (ÔÒ) 2,2'-dithiodiethanesulfonic acid :"
  • coenzyme Q
    º¸È¿¼Ò(ÜÍý£áÈ) Q
  • coenzyme Q-cytochrome c reductase complex
    º¸È¿¼Ò(ÜÍý£áÈ) Q¡¤»çÀÌÅäÅ©·Ò C ¸®´ÚÅ×À̽º (ÔÒ) complex III
  • coenzyme R
    "º¸È¿¼Ò(ÜÍý£áÈ) R, (ÔÒ) biotin"
  • cold-sensitive enzyme
    ³Ã¹Î°¨ È¿¼Ò(Ò²ÚÂÊïý£áÈ)
  • clod-stable enzyme
    ³Ã¾ÈÁ¤ È¿¼Ò(Ò²äÌïÒý£áÈ)
  • Compton effect
    ÄÞÅæ È¿°ú(üùÍý)
  • condensing enzyme
    ÃàÇÕÈ¿¼Ò(õêùêý£áÈ)
  • conjugated enzyme
    Á¢ÇÕÈ¿¼Ò(ïÈùêý£áÈ)
  • constitutive enzyme
    ±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • respiratory dead space
    È£Èí¼º¹«È¿°ø°£
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • RF antennae effect
    °íÁ֯ľÈÅ׳ªÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú
  • siphonage effect
    ½ÎÀÌÆùÈ¿°ú
  • spatial presaturation effect
    °ø°£ÀüÆ÷È­È¿°ú
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • T1 shortening effect
    T1´ÜÃàÈ¿°ú
  • T2 shortening effect
    T2´ÜÃàÈ¿°ú
  • utility
    ¼Òºñ·®, À¯¿ë¼º, È¿¿ë
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • R83.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • R84.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • R85.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • R86.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • R87.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • converting enzyme
    Àüȯ È¿¼Ò
  • cost-effectiveness
    ºñ¿ë È¿À²
  • cryptococcal meningitis
    È¿¸ð±Õ¼º ³ú¸·¿°
  • Cryptococcosis
    È¿¸ð±ÕÁõ, Å©¸³ÅäÄÚÄ¿½º º´, Å©¸³ÅäÄÛÄí½ºÁõ
    1. Áø±Õ·ùÀÇ ÀÏÁ¾ÀÎ Cri
  • Cryptococcus dermitidis
    °¡¼º È¿¸ð±Õ
  • Cryptococcus hominis
    ³ó¾ç È¿¸ð±Õ, Å©¸³ÅäÄÛÄí½º È£¹Ì´Ï½º
  • curative dose
    ġȿ·®
  • cytochrome oxidase test
    »çÀÌÅäÅ©·Ò »êÈ­ È¿¼Ò °Ë»ç
  • cytohydrolist
    ¼¼Æ÷¸· °¡¼öºÐÇØ È¿¼Ò
    ¼¼Æ÷ º®À» °¡¼öºÐÇØ¿¡ ÀÇÇÏ¿© ÆÄ±«ÇÏ´Â È¿¼Ò.
  • cytopathogenic effect
    ¼¼Æ÷ º¯¼º Çö»ó, ¼¼Æ÷ º´º¯ È¿°ú
  • dead space
    »ç°­, ¹«È¿ °ø°£
  • decarboxylation
    Żī¸£º¹½Ç ¹ÝÀÀ, Żī¸£º¹½Ç È¿¼Ò ¹ÝÀÀ, Żī¸£º¹½Ç ÀÛ¿ë
  • Deelman`s effect
    µ¨¸¸ È¿°ú
  • dehydrase
    Å»¼ö¼Ò È¿¼Ò
    Å»¼ö¼Ò È¿¼Ò¿Í Å»¼ö È¿¼Ò ¾çÀÚ¿¡ »ç¿ëµÇ¾ú´ø ¿¾ ¿ë¾î.
  • deiodinase
    Å»À̿ ȿ¼Ò
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Doppler Lidar System
    µµÇ÷¯ È¿°ú¸¦ ÀÌ¿ëÇÑ ±¤ÇÐ½Ä ¼Óµµ°è
  • Doppler effect
    µµÇ÷¯ È¿°ú 
  • ED
    effectove dpse.(¾àÀÇ)À¯È¿·®;environmental disruption ȯ°æ ÆÄ±«
  • EER
    energy efficiency ratio(Àü)¿¡³ÊÁö È¿À²ºñ o
  • EHP
    effective horse power À¯È¿ ¸¶·Â;electrical horse power Àü±â ¸¶·Â
  • EPNdB
    effective perceived noise decibels °¨°¢ ¼ÒÀ½ È¿°ú µ¥½Ãº§
  • G.T.C.
    good till canceled (countermanded) Ãë¼ÒÇÒ ¶§±îÁö À¯È¿
  • Halaphone
    ÇÒ¶óÆù(ÀüÀÚ À½Çâ(È¿°ú) ÀåÄ¡(¾Ç±â);¿ÀÄɽºÆ®¶ó ¿¬ÁÖ Áß¿¡ °®°¡Áö À½Çâ È¿°ú¸¦ ´õÇØ ÁÖ´Â
  • IU
    international unit (»ý)ºñŸ¹Î·®È¿°ú ÃøÁ¤¿ë);±¹Á¦ ´ÜÀ§
  • Lasparaginase
    ¿¤ ¾Æ½º¶óÆÄ±â³ª¾ÆÁ¦(¹éÇ÷º´ Ä¡·á¿ë È¿¼Ò)
  • MOSFET
    ±Ý¼Ó »êÈ­¸· ¹ÝµµÃ¼ Àü°è È¿°ú Æ®·£Áö½ºÅÍ
  • NAD
    nicotinamide-adenine dinucleotide(»ýÈ­)´ÏÄÚÆ¾ ¾Æ¹Ìµå ¾Æµ¥´Ñ µð´©Å¬·¹¿ÀƼµå(º¸Á¶È¿¼ÒÀÇ ÀÏÁ¾)no appreciable disease;nothing abnormal discovered
  • Ovonic
    ¿Àºê½Å½ºÅ° È¿°ú;¿Àº¸´Ð ÀåÄ¡
  • RNA polymerase
    RNA Æ÷¸®¸Þ¶óÁ¦(¸®º¸ÇÙ»ê ÇÕ¼ºÈ¿¼Ò)
  • RNA replicase
    RNA ·¹Çø®Ä«Á¦(RNAÇÕ¼ºÈ¿¼Ò)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á